You just read:

Morphotek Announces Sponsored Research Agreement With Fox Chase Cancer Center To Study Immunosuppressive Effects Of Tumor Shed Antigens To Improve Future Patient Therapies

News provided by

Morphotek, Inc.

Sep 13, 2016, 10:00 ET